AU Stock MarketDetailed Quotes

ACR Acrux Ltd

Watchlist
  • 0.023
  • 0.0000.00%
20min DelayTrading May 7 11:12 AET
9.37MMarket Cap-1.15P/E (Static)

About Acrux Ltd Company

Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.

Company Profile

SymbolACR
Company NameAcrux Ltd
Founded1998
MarketASX
Employees36
Fiscal Year Ends06-30
Address103-113 Stanley Street West Melbourne
CityMelbourne
CountryAustralia
Zip Code3003
Phone+61 383790100
Share RegistryMUFG CORPORATE MARKETS (AU) LIMITED Tower 4, 727 Collins Street, DOCKLANDS, VIC, AUSTRALIA, 3008 1300 554 474

Company Executives

  • Name
  • Position
  • Salary
  • Michael John Kotsanis
  • Chief Executive Officer,Managing Director
  • --
  • Ross Dobinson
  • Non-Executive Chairman,Non-Executive Director
  • --
  • Timothy Oldham
  • Non-Executive Director
  • --
  • Geoffrey E.D Brooke
  • Non-Executive Director
  • --
  • Donald Charles Brumley
  • Non-Executive Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More